# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000886163-24-000022
Filing Date
2024-04-25
Accepted
2024-04-24 19:33:34
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | a202310-k_printxclean.pdf | ARS | 2724037
| Complete submission text file | 0000886163-24-000022.txt |  | 3753474

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33093 | Film No.: 24872346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)